Comparing long‐term outcomes between drug‐eluting and bare‐metal stents in the treatment of cardiac allograft vasculopathy
Catheterization and Cardiovascular Interventions2009Vol. 74(4), pp. 543–549
Citations Over TimeTop 19% of 2009 papers
Abstract
This study suggests that after PCI for cardiac allograft vasculopathy, despite a lower in-stent restenosis rate in DES compared with BMS, in-segment restenosis and clinical cardiac endpoints are similar.
Related Papers
- → Repeated drug-eluting stent implantation for drug-eluting stent restenosis: The same or a different stent(2007)86 cited
- → Clinical outcomes by optical characteristics of neointima and treatment modality in patients with coronary in-stent restenosis(2021)34 cited
- → Same or Different Drug‐Eluting Stent Re‐Implantation for Drug‐Eluting Stent Restenosis: An Assessment Including Second‐Generation Drug‐Eluting Stents(2016)2 cited
- → AS-40: Percutaneous Coronary Interventions with Drug-Eluting Stent Implantation in Cases of Drug-Eluting Stents Restenosis(2009)
- Clinical study of different treatment strategy for AMI patients treated by primary PCI with multi-vessel coronary artery disease(2009)